They studied the prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes, and found highly variable ratios of VHL mutations and 3p deletions in the different histological subtypes of kidney tumors. The gene discussed is VHL; the disease is kidney neoplasm.